Recent developments in the immunology of inflammatory bowel disease.
about
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironmentStructural basis by which alternative splicing confers specificity in fibroblast growth factor receptorsSynbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trialRhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis.Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarizationCD43 potentiates CD3-induced proliferation of murine intestinal intraepithelial lymphocytesAcute and persisting Th2-like immune response after fractionated colorectal gamma-irradiationCaffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after gamma-irradiation in the rat by modulating the cytokine patternMechanisms of Natural Tolerance in the IntestineMolecular mimicry may contribute to pathogenesis of ulcerative colitis.Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitisManipulation of cytokines in the management of patients with inflammatory bowel disease.The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota.Clinical aspects and pathophysiology of inflammatory bowel disease.TNF ligands and receptors--a matter of life and death.Immunoregulation in the gut: success and failures in human disease.Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis.Oral aspects of Crohn's disease.Expression and significance of nuclear factor kappaB p65 in colon tissues of rats with TNBS-induced colitis.Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis.Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis.Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.Gastrointestinal parasites: potential therapy for refractory inflammatory bowel diseases.Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants.Immunopathogenesis of Crohn's disease.Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitisPropionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseasesMyofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells.HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats.IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine.What can we learn about biofilm/host interactions from the study of inflammatory bowel disease.Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.Biological pathways involved in the development of inflammatory bowel disease.Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis.CD4⁺ T cell cytokine gene and protein expression in duodenal mucosa of dogs with inflammatory bowel disease.
P2860
Q21562212-2B1963FC-19B4-45DE-AD26-217615874E75Q24294933-40DA3E73-908A-4C28-B34C-19EFA010629AQ24685494-E423F45C-070A-4079-A37A-454F9C02BD95Q24814625-5DD6B574-3C51-4E3A-A1A8-53B7B417E7B4Q27301176-3A61B77F-569E-4F66-B4AE-40846A59A46AQ28510363-0ED55873-E5B4-4B26-9022-8DD20148AA82Q28566305-4E44D84A-4B84-4411-B988-B58276A7BC0BQ28567815-8B7AA229-E1A3-4E38-BAF7-1B9D2868CC6BQ29031968-169EBB82-77DB-4FFD-AA3F-D38EE89E84D2Q31162559-D6673096-79C3-4814-973F-D508FB7EB926Q33714931-E76E68C4-9FCD-4128-83D1-600BA3F9323FQ34111896-66CA74C7-AB37-47C0-AA83-0AB72392D71DQ34156291-2D8BDE96-DA89-435B-B644-DE11434079BCQ34487217-11CF24FE-626D-4E0D-AF72-FC669D049007Q34542205-4234FD5C-3063-4D2F-8567-8C1A40B6D935Q34601009-05CA98C2-DE26-45FA-A7B8-2B4F1653A218Q34606191-711EE9BD-9E29-4AD1-B8E3-708F36B1B5A7Q34713611-DBD72EF4-E99F-40DF-88CE-3CAFAABC0047Q35011060-FB6591EF-5C75-4558-A9F0-B71D15F8C7DDQ35033801-0029C54B-79EC-430B-8BBC-BF932FE42889Q35106581-F8EF0B79-19E8-4242-BA49-3942FEA4800AQ35594688-A582BD0A-50C3-4CB4-8460-2657275DE6BCQ35594777-63C047A7-6137-45F5-A672-9A98567A74D1Q35596242-410E2434-24ED-4E22-A345-7FD1F6040174Q35748975-135E0C2B-2996-47DC-BEAB-B4F0ED9B4DC3Q36022832-73DDBDA0-9687-4C34-9B41-6FDFD9E59F0FQ36165341-9E137FB5-1907-49F8-B8A7-66120BC48266Q36175758-6ED84817-A0D8-4579-9ABC-9D6B4946290DQ36178445-6A742EF4-FCBC-4B6D-B05D-9A011F9A21E0Q36285788-F52B47FF-3A7F-4BB1-8FE3-138524C4B847Q36676237-3903BF2B-A3EC-4294-8598-67A278DCACEAQ36807040-EA30A319-606C-41EA-BEFF-C3354CFD30C7Q36808165-D3F25D0A-549E-4F4D-A216-36708672A612Q37203835-D798C662-F988-4ED6-A31D-6E0D49C0D5D6Q37362590-9B44D10F-B93C-4E56-9508-AFFD4C3018E4Q37842621-2A4795C6-DD27-43B3-A2FA-20340E0C33F9Q37969751-CBEA04A5-F0A6-42F9-AEB7-3EBC7A5B1F9CQ38254327-32E061CB-DD99-4C1A-886C-9BD112C75875Q39254977-3A534A47-51B1-4D85-BFE4-67923B4F53A4Q39348680-6DF88A95-613D-4E6C-924C-406A6B62F001
P2860
Recent developments in the immunology of inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recent developments in the immunology of inflammatory bowel disease.
@ast
Recent developments in the immunology of inflammatory bowel disease.
@en
type
label
Recent developments in the immunology of inflammatory bowel disease.
@ast
Recent developments in the immunology of inflammatory bowel disease.
@en
prefLabel
Recent developments in the immunology of inflammatory bowel disease.
@ast
Recent developments in the immunology of inflammatory bowel disease.
@en
P2093
P1476
Recent developments in the immunology of inflammatory bowel disease.
@en
P2093
MacDonald TT
Monteleone G
P356
10.1046/J.1365-3083.2000.00658.X
P577
2000-01-01T00:00:00Z